Results 71 to 80 of about 77,179 (290)

Polypharmacy burden and incident epilepsy among older adults in the United States

open access: yesEpilepsia Open, EarlyView.
Abstract Objectives To estimate the prevalence of polypharmacy among older adults with incident epilepsy and to describe the most common combinations of drug classes filled prior to epilepsy diagnosis. Polypharmacy—the concurrent use of multiple medications—is common in older adults with epilepsy, but little is known about its burden and specific ...
Galen Shearn‐Nance   +9 more
wiley   +1 more source

KADAR IODIUM DALAM GARAM PADA DAERAH DENGAN KASUS HIPOTIROID DAN HIPERTIROID TINGGI

open access: yesMedia Gizi Mikro Indonesia, 2017
Background. Iodized salt is universal effort to eliminate iodine deficiency disorders (IDD). Iodine consentration in iodized salt needs to be evaluated due to many cases of hypothyroid and hyperthyroidism. Objective.
Ika Puspita Asturiningtyas, Ina Kusrini
doaj   +1 more source

Depression and anxiety in hyperthyroidism [PDF]

open access: yes, 2002
Background. Our objective was to determine symptomatology of depression and anxiety in patients with untreated hyperthyroidism and compare with euthyroid patients. Methods.
Demet M.M.   +5 more
core   +1 more source

A Multicenter, Open‐Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST)

open access: yes
American Journal of Hematology, EarlyView.
Kenneth I. Ataga   +8 more
wiley   +1 more source

Development of a Zebrafish Embryo‐Based Test System for Thyroid Hormone System Disruption: 3Rs in Ecotoxicological Research

open access: yesEnvironmental Toxicology and Chemistry, EarlyView.
Abstract There is increasing concern regarding pollutants disrupting the vertebrate thyroid hormone (TH) system, which is crucial for development. Thus, identification of TH system–disrupting chemicals (THSDCs) is an important requirement in the Organisation for Economic Co‐operation and Development (OECD) testing framework.
Lisa Gölz   +9 more
wiley   +1 more source

Influence of subclinical hyperthyroidism on the cardiovascular system

open access: yesКлиническая и экспериментальная тиреоидология, 2015
Subclinical hyperthyroidism occurs when the serum TSH is below the lower limit of the reference range and the free T4 and T3 concentrations are normal. Тhe clinical significance of subclinical hyperthyroidism is much debated.
T Y Demidova, I N Drozdova
doaj   +1 more source

Hyperthyroidism and Graves' Disease [PDF]

open access: yes, 2011
Hyperthyroidism is an important condition: it affects 1–2% of the UK population and has a huge impact on quality of life. Because hyperthyroidism often presents asymptomatically or with non-specific symptoms, the diagnosis can be easily missed.
Fiona Grayston
core   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Subclinical hyperthyroidism [PDF]

open access: yes, 2011
Subclinical hyperthyroidism is defined biochemically as the association of a low serum thyroid-stimulating hormone (TSH) value with normal circulating concentrations of free thyroxine (T4) and free triiodothyronine (T3).
Jayne A. Franklyn
core   +1 more source

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19‐09, CONPELAN Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The benefit of consolidation programmed cell death protein 1 (PD‐1) blockade after chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. Methods Patients with stages II–IVB NPC were randomized (2:1) to pembrolizumab 200 mg or placebo every 3 weeks for up to 17 cycles after chemoradiotherapy ...
Sang Hoon Chun   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy